Literature DB >> 2429859

Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.

M Herrera-Marschitz, I Christensson-Nylander, T Sharp, W Staines, M Reid, T Hökfelt, L Terenius, U Ungerstedt.   

Abstract

In the present study the functional role of the striato-nigral dynorphin and substance P pathways in rat brain has been studied using the rotational behavioural model and an intracerebral dialysis technique complemented with brain lesions and immunohistochemical analysis. Attempts were made to evaluate whether these striato-nigral neurons have a feed-back modulatory action on the dopaminergic nigro-striatal system, or whether they represent an outflow pathway conveying motor information from the striatum. Unilateral injection of dynorphin A into the substantia nigra reticulata of naive rats induced contralateral rotational behaviour. This effect was dose-dependent and mimicked by the kappa-opioid receptor agonist, U50,488H. Intranigral injection of substance P, as well as substance K, also produced dose-dependent contralateral rotational behaviour. Unilateral injections of ibotenic acid into various sites of the striatum were used to destroy the striato-nigral pathways. The lesions produced a depletion of dynorphin- and substance P-like immunoreactivity in the pars reticulata of the substantia nigra ipsilateral to the lesion and markedly affected the behavioural responses to intranigral peptide injections. Dynorphin A more potently induced contralateral rotation in the lesioned compared to naive non-lesioned rats, suggesting development of supersensitivity for this peptide. Substance P on the other hand, was markedly less potent in inducing rotation in lesioned animals. The rotational responses to both dynorphin A and substance P were potentiated by injection of amphetamine 1 h later, suggesting that both peptides act via nigro-striatal dopamine neurons. However, in rats with unilateral nigro-striatal dopamine denervation, produced with 6-hydroxy-dopamine, dynorphin A retained its potency to induce rotational behaviour; substance P was again much less potent. Thus, both the ibotenic acid and 6-hydroxy-dopamine lesions differently affect the action of dynorphin A and substance P in the zona reticulata of the substantia nigra. The data suggests that substance P requires an intact dopamine pathway to produce the rotational response, while dynorphin A does not. Direct evidence that behavioural activation produced by dynorphin A is not dependent upon dopamine stimulation was obtained by intrastriatal dialysis experiments in which changes in striatal dopamine release were measured following intranigral injection of dynorphin A or substance P. Intranigral dynorphin A in fact reduced, while substance P increased the release of dopamine.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2429859     DOI: 10.1007/bf00238214

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  107 in total

1.  Demonstration and distribution of kassinin-like material (substance K) in the rat central nervous system.

Authors:  C W Shults; H Yajima; H G Gullner; T N Chase; T L O'Donohue
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

Review 2.  The striatum and substantia nigra: a commentary on their relationships.

Authors:  A Dray
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

3.  Distribution of immunoreactive dynorphin in the central nervous system of the rat.

Authors:  N Zamir; M Palkovits; M J Brownstein
Journal:  Brain Res       Date:  1983-11-28       Impact factor: 3.252

4.  Regional distribution of kassinin-like immunoreactivity in rat central and peripheral tissues and the effect of capsaicin.

Authors:  J E Maggio; J C Hunter
Journal:  Brain Res       Date:  1984-07-30       Impact factor: 3.252

5.  The distribution of immunoreactive alpha-neo-endorphin in the central nervous system of the rat.

Authors:  N Zamir; M Palkovits; M J Brownstein
Journal:  J Neurosci       Date:  1984-05       Impact factor: 6.167

6.  Substance P release from the rat substantia nigra.

Authors:  T M Jessell
Journal:  Brain Res       Date:  1978-08-11       Impact factor: 3.252

7.  On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra.

Authors:  M J Brownstein; E A Mroz; M L Tappaz; S E Leeman
Journal:  Brain Res       Date:  1977-10-28       Impact factor: 3.252

8.  Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.

Authors:  T Zetterström; T Sharp; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

9.  Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. II: The striatum of the rat is heterogeneously organized for rotational behaviour.

Authors:  M Herrera-Marschitz; C Forster; U Ungerstedt
Journal:  Acta Physiol Scand       Date:  1985-11

10.  Two distinct strio-nigral substance P pathways in the rat: an experimental immunohistochemical study.

Authors:  J Kohno; S Shiosaka; K Shinoda; S Inagaki; M Tohyama
Journal:  Brain Res       Date:  1984-08-13       Impact factor: 3.252

View more
  13 in total

1.  Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study.

Authors:  A M Cortez; S Charntikov; T Der-Ghazarian; L R Horn; C A Crawford; S A McDougall
Journal:  Neuroscience       Date:  2010-05-05       Impact factor: 3.590

2.  Distinct presynaptic control of dopamine release in striosomal and matrix areas of the cat caudate nucleus.

Authors:  M L Kemel; M Desban; J Glowinski; C Gauchy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 3.  Organization and physiology of the substantia nigra.

Authors:  H Condé
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

4.  Two different types of dynorphin-A-immunoreactive terminals in rat substantia nigra.

Authors:  R Riesenberg; C Nitsch
Journal:  Cell Tissue Res       Date:  1990-07       Impact factor: 5.249

5.  Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

Authors:  I Christensson-Nylander; M Herrera-Marschitz; W Staines; T Hökfelt; L Terenius; U Ungerstedt; C Cuello; W H Oertel; M Goldstein
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

6.  Neurocircuitry of the basal ganglia studied by monitoring neurotransmitter release. Effects of intracerebral and perinatal asphyctic lesions.

Authors:  M Herrera-Marschitz; C F Loidl; Z B You; K Andersson; R Silveira; W T O'Connor; M Goiny
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

7.  The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.

Authors:  M P Hill; J M Brotchie
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

8.  Effects of dorsal striatal infusions of R(-)-propylnorapomorphine on kappa-opioid-mediated locomotor activity in the young rat: possible role of the indirect pathway.

Authors:  S Charntikov; L R Halladay; M S Herbert; E M Marquez; S A McDougall
Journal:  Neuroscience       Date:  2008-06-14       Impact factor: 3.590

9.  The postsynaptic targets of substance P-immunoreactive terminals in the rat neostriatum with particular reference to identified spiny striatonigral neurons.

Authors:  J P Bolam; P N Izzo
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

10.  The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.

Authors:  I Nylander; M Vlaskovska; L Terenius
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.